Buscar
Cerrar este cuadro de búsqueda.

AcexHealth celebra su Investor Day con el pitch de las startups participantes

Acexhealth Investor Day

La sede de la Fundación PTS acoge mañana viernes 2 de febrero, la celebración del AcexHealth Investor Day. Jornada con la que concluye la tercera edición de AcexHealth, la aceleradora andaluza de empresas del sector salud, y que contribuirá a conectar talento, innovación e inversión.

Tras un itinerario formativo de 5 meses en el que los participantes trabajan su proyecto de negocio para hacerlo viable en el mercado y conseguir financiación con éxito, cada empresa tendrá la posibilidad de presentar, en un pitch de 10 minutos, su empresa, la tecnología aplicada y la oportunidad de negocio a los inversores presentes.

Finalizada la ronda de presentaciones, un jurado formado por mentores, inversores, organizadores, y patrocinadores, elegirán a las 4 mejores compañías del sector salud de Andalucía, ganadoras de los Premios AcexHealth.

Agenda:

  • 9:00 – 11:00 Visita guiada a PTS Granda (opcional)
  • 11:00 – 11:30 Bienvenida
  • 11:30 – 12:45 Presentación de Pitch – Bloque 1
    • 11:30am Prottech
      A belt that cushions the impact on the hip in case of a fall, monitors and alerts family members automatically. Reassembles instantly, and without tools. It will serve as a tool for doctors to assess the risk of falls.
      Project Category: MedTech. Web: https://prottech.es/
    • 11:45pm CRISPNA
      Development of effective and safe therapeutic treatments for Cancer with the purpose of restoring hope to patients who have no other option. They have been studying cancer and especially its relationship with inflammation for more than 7 years. At CRISPNA Bio, we redefine genetic innovation, presenting a unique CRISPNA technology that seamlessly integrates CRISPR with the exceptional benefits of Peptide Nucleic Acids (PNA). Our
      groundbreaking approach could enhance the efficacy of genetic interventions, making CRISPNA Bio a frontrunner in therapy and diagnostic applications.
    • 12:00 pm mDurance
      Measure muscle activity to decide the best solution for your patients. The wearable electromyograph that gets you results in real time
      Project Category: MedTech. Web: https://mdurance.com/
    • 12:15pm Cobiomics
      Improving patient lives, saving time and cost to the healthcare systems using a novel companion diagnostic kit. A tool that helps to identify the correct medications for the right patients suffering from Autoimmune – Inflammatory diseases.
      Project Category: Biotech. Web: https://cobiomic.com/
    • 12:30pm Destina Genomics
      A Growth Investment Opportunity to Launch DESTINA’s Singleplex and COMBO LiverAce Kits into Liver Toxicology Markets.
      Project Category: Biotech. Web: https://destinagenomics.com/
  • 12:45 – 13:00 Café – Networking
  • 13:00-14:30 Presentación de Pitch – Bloque 2
    • 13:00 pm UbitelCare
      Global System for Monitoring and Remote Control of Heart Failure and Arrhythmia pathologies through the exhaustive control of an extensive number of clinical variables.
      Project Category: MedTech. Web: http://www.ubitelcare.es/
    • 13:15pm Wosler
      Wosler is a multilateral platform that optimizes and manages the outpatient care of patients in the tourism sector in Spain. It is designed to be the perfect link between quality care for the tourism sector, thus improving their experience and achieving an improvement through the
      optimization and decompression of the public health system in Spain.
      Project Category: Digital Health. Web: https://www.wosler.es/
    • 13:30pm KAT Innovation
      KAT Innovation’s OSTAAT is the first solution to address the unmet need for osteoporosis treatment in patients with severe chronic kidney disease. Furthermore, OSTAAT is the only non-invasive, side-effect-free option for treating osteoporosis, reducing fracture risk by promoting a
      remarkable 2.01% bone growth in just 30 hours of session over 10 weeks. This shorter, more cost-effective treatment period surpasses the performance of competitors in the 15-billion-euro annual sales market.
    • 13:45pm Regemat
      Regemat3D designs and manufactures technologies which integrate the advantages of additive manufacturing with tissue engineering for applications in regenerative medicine and personalized treatment development.
      Project Category: MedTech. Web: https://www.regemat3d.com/en
    • 14:00 Medicsen
      Medicsen has developed the first device capable of administering large drugs such as insulin or antibodies without needles or cannulas, in wearable format and controllable through digital tools, using ultrasound waves to transiently increase skin permeability.
      Project Category: MedTech. Web: https://www.medicsen.com/
  • 14:30 – 16:00 Almuerzo – Networking
  • 16:00 – 16:30 Entrega Premios AcexHealth
Compartir en
Buscar
Cerrar este cuadro de búsqueda.